Personal information

Gastric cancer, Colon cancer, Inflammation, Cytokine signalling, JAK kinases, Tuft cells, Doublecortin-like kinase 1, Group 2 Innate Lymphoid cells
Australia, France, Switzerland

Activities

Employment (7)

Olivia Newton-John Cancer Research Institute: Heidelberg, VIC, AU

2025-01-01 to present | Scientific Laboratory Head (School of Cancer Medicine)
Employment
Source: Self-asserted source
Michael Buchert

Olivia Newton-John Cancer Wellness & Research Centre: Heidelberg, VIC, AU

2018-01-01 to 2024-12-31 | Group Leader (School of Cancer Medicine)
Employment
Source: Self-asserted source
Michael Buchert

Olivia Newton-John Cancer Research Insitute: Melbourne, VIC, AU

2015 to 2017-12-31 | Senior Postoctoral Fellow (School of Cancer Medicine)
Employment
Source: Self-asserted source
Michael Buchert

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

2012 to 2014 | Senior Research Fellow (Cell Signaling and Cell Death)
Employment
Source: Self-asserted source
Michael Buchert

Ludwig Institute for Cancer Research, Parkville Branch: Melbourne, VIC, AU

2007 to 2012 | Assistant Investigator
Employment
Source: Self-asserted source
Michael Buchert

Institut de Génomique Fonctionnelle: Montpellier, FR

2002 to 2007 | Postdoctoral Fellow (Département de l’Oncologie Cellulaire et Moléculaire (OCM))
Employment
Source: Self-asserted source
Michael Buchert

Royal Melbourne Hospital: Melbourne, VIC, AU

1999 to 2002 | Postdoctoral Fellow (Department of Surgery)
Employment
Source: Self-asserted source
Michael Buchert

Education and qualifications (3)

University of Zurich: Zurich, CH

1995 to 1998 | PhD (Department of Medical Virology)
Education
Source: Self-asserted source
Michael Buchert

University of Zurich: Zurich, CH

1989 to 1994 | Bachelor od Science (Faculty of Science)
Education
Source: Self-asserted source
Michael Buchert

Kantonschule St. Gallen: St. Gallen, CH

1984 to 1988 | High School Graduation
Education
Source: Self-asserted source
Michael Buchert

Funding (13)

Evaluation of circulating immune cell subtypes for the early detection of stomach cancer

2022-01 to 2022-12 | Grant
Tour de Cure (NSW, NSW, AU)
Source: Self-asserted source
Michael Buchert

Exploiting the cross talk between Tuft cells and group 2 innate lymphoid cells for tissue homeostasis and disease

2018-01 to 2020-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER:

APP1143020

Source: Self-asserted source
Michael Buchert

The FGFR family as drivers and biomarkers of regorafenib response in gastric cancer

2017-01 to 2019-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
Part of GRANT_NUMBER:

APP1126094

Source: Self-asserted source
Michael Buchert

Role of MACROD2 Loss in DNA Repair, Chromosomal Instability and Development of Colorectal Cancer: Clinical and Therapeutic Implications

2015-01 to 2017-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
Part of GRANT_NUMBER:

APP1079364

Source: Self-asserted source
Michael Buchert

Targeting colorectal cancer with Jak kinase inhibitors

2014 to 2016 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER:

APP1064987

Source: Self-asserted source
Michael Buchert

Molecular elucidation of PI3K/mTor pathway as a therapeutic target in inflammation-associated (gastrointestinal) cancers

2011 to 2014 | Grant
Cancer Council Victoria (VIC, VIC, AU)
GRANT_NUMBER:

APP1028442

Source: Self-asserted source
Michael Buchert

The Contribution of gp130/Stat3 Signaling to Wnt/β-catenin-dependent Intestinal Cancer

2010 to 2012 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER:

APP603127

Source: Self-asserted source
Michael Buchert

Comprehensive analysis of colon cancer

2008 to 2013 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
Source: Self-asserted source
Michael Buchert

The role of tight junctions in epithelial cancers

2004 to 2006 | Salary award
Association pour la Recherche sur le Cancer (Paris, FR)
Source: Self-asserted source
Michael Buchert

The role of the tight junction-associated protein Symplekin in colon cancer

2003 to 2004 | Salary award
French Ministry of Foreign Affairs (Paris, FR)
Source: Self-asserted source
Michael Buchert

The role of the tight junction-associated protein Symplekin in colon cancer

2002 to 2003 | Salary award
Swiss National Science Foundation (Bern, CH)
Source: Self-asserted source
Michael Buchert

The role of tight junction-associated protein Symplekin in epithelial cells

2001 to 2002 | Salary award
Roche Research Foundation (Basel, CH)
Source: Self-asserted source
Michael Buchert

The role of AF6 in neurogensis

1999 to 2001 | Salary award
Swiss National Science Foundation (Bern, CH)
Source: Self-asserted source
Michael Buchert

Peer review (2 reviews for 1 publication/grant)

Review activity for BMC gastroenterology (2)